Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Extendicare Inc. (EXE.TO)
CAD37.16
+0.06 (+0.16%)
CA TSX Healthcare Medical - Care Facilities
Address
3000 Steeles Avenue East L3R 4T9
Markham, ON, CA
Markham, ON, CA
CEO
David E. Bacon
Website
extendicare.com
IPO
2012-09-24
ISIN CA30224T8639
Also trades on
London Stock Exchange · 0S9E.L (CAD)
Other OTC · EXETF (USD)
Toronto Stock Exchange · EXE.TO (CAD)
Description
Extendicare Inc. operates across Canada, delivering a wide array of vital care and support services specifically designed for the senior population through its various subsidiaries. The company's diverse service portfolio includes long-term care facilities, a range of retirement living options, and comprehensive home-based health services. These home health offerings span professional nursing care, various rehabilitative therapies (including occupational, physical, and speech therapy), and assistance with everyday activities. Additionally, Extendicare offers contract and consulting expertise to external entities. The organization oversees an extensive network consisting of 119 long-term care residences and retirement communities, alongside its dedicated home health care operations. These services are provided under prominent brand names such as Extendicare, Esprit Lifestyle Communities, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network. Founded in 1968, Extendicare Inc. is headquartered in Markham, Canada.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
CAD37.16
+0.06 (+0.16%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
435.5K
Beta
1.15
Float Shares
93.34M
Free Float %
98.4%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.53% | +0.35% | +8.66% | +27.97% | +66.74% | +49.79% | +120.55% | +339.29% | +316.41% | +251.04% | +109.70% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (1 ratings, all time)
Hold
Price Targets & DCF
Current price
37.16
DCF (Unlevered)
0.08
-99.8%
DCF (Levered)
1.86
-95.0%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 4 | 0 |
| Buy | 4 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
4.68
Safe zone
Piotroski F-Score
5 / 9
Average
MOAT Score
4 / 10
Developing
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
2 / 5
Medium
ROE Score
5 / 5
High
ROA Score
5 / 5
High
D/E Score
1 / 5
Low
P/E Score
3 / 5
Medium
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%+13.3% ★ Q1'26: +24.2% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+29.1% ★ Q1'26: +133.3% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+8.6% ★ Q1'26: -2.6% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+8.3% Q1'26: +9.2% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+28.0% ★ Q1'26: +35.6% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%-8.9% ★ Q1'26: +13.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×1.95× ★ Q1'26: 1.54× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2009 actual |
Dec 2010 actual |
Dec 2011 actual |
Dec 2012 actual |
Dec 2013 actual |
Dec 2014 actual |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 4 Rev. Ana. 6 EPS Ana. |
Dec 2027 4 Rev. Ana. 6 EPS Ana. |
Dec 2028 2 Rev. Ana. 3 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.17B
est: 2.24B (-3.2%)
|
2.07B
est: 1.40B (+48.1%)
|
2.09B
est: 2.11B (-0.7%)
|
2.04B
est: 2.07B (-1.7%)
|
783.81M
est: 2.04B (-61.6%)
|
816.12M
est: 789.67M (+3.3%)
|
943.28M
est: 1.18B (-20.2%)
|
1.06B
est: 1.06B (+0.1%)
|
1.10B
est: 1.10B (-0.4%)
|
1.12B
est: 1.11B (+0.9%)
|
1.13B
est: 1.13B (+0.3%)
|
1.10B
est: 1.13B (-2.6%)
|
1.17B
est: 1.25B (-7.0%)
|
1.22B
est: 1.23B (-0.4%)
|
1.30B
est: 1.39B (-6.0%)
|
1.47B
est: 1.44B (+1.9%)
|
1.66B
est: 1.66B (+0.2%)
|
2.20B
2.13B – 2.24B
+32.6% YoY
|
2.39B
2.36B – 2.49B
+8.8% YoY
|
2.50B
2.49B – 2.50B
+4.5% YoY
|
| EBITDA |
290.23M
est: 234.99M (+23.5%)
|
237.28M
est: 118.94M (+99.5%)
|
144.41M
est: 241.86M (-40.3%)
|
180.31M
est: 159.82M (+12.8%)
|
72.78M
est: 86.04M (-15.4%)
|
73.72M
est: 10.51M (+601.1%)
|
92.66M
est: 24.43M (+279.2%)
|
97.40M
est: 375.62M (-74.1%)
|
102.37M
est: 59.98M (+70.7%)
|
75.37M
est: 21.22M (+255.2%)
|
87.72M
est: 49.40M (+77.6%)
|
125.79M
est: 51.06M (+146.3%)
|
67.46M
est: 51.39M (+31.3%)
|
48.90M
est: 52.87M (-7.5%)
|
98.63M
est: 106.92M (-7.8%)
|
155.27M
est: 82.09M (+89.2%)
|
175.61M
est: 127.66M (+37.6%)
|
169.26M
164.36M – 172.24M
+32.6% YoY
|
184.17M
181.39M – 191.52M
+8.8% YoY
|
192.41M
191.91M – 192.90M
+4.5% YoY
|
| EBIT |
222.82M
est: 163.67M (+36.1%)
|
163.40M
est: 78.46M (+108.2%)
|
67.75M
est: 146.90M (-53.9%)
|
103.50M
est: 104.91M (-1.3%)
|
50.80M
est: 97.08M (-47.7%)
|
49.52M
est: 26.36M (+87.8%)
|
68.64M
est: 44.93M (+52.8%)
|
65.87M
est: 77.06M (-14.5%)
|
70.65M
est: 59.89M (+18.0%)
|
39.90M
est: 66.76M (-40.2%)
|
50.72M
est: 39.40M (+28.7%)
|
86.99M
est: 47.90M (+81.6%)
|
36.43M
est: 48.20M (-24.4%)
|
17.20M
est: 49.59M (-65.3%)
|
66.41M
est: 72.94M (-9.0%)
|
121.94M
est: 75.51M (+61.5%)
|
138.37M
est: 87.08M (+58.9%)
|
115.46M
112.12M – 117.49M
+32.6% YoY
|
125.63M
123.73M – 130.64M
+8.8% YoY
|
131.25M
130.91M – 131.59M
+4.5% YoY
|
| Net Income |
77.71M
est: 104.32M (-25.5%)
|
51.69M
est: 48.46M (+6.7%)
|
-30.40M
est: 78.05M (-138.9%)
|
62.66M
est: 42.59M (+47.1%)
|
5.28M
est: 61.80M (-91.5%)
|
-18.75M
est: 2.05M (-1,015.3%)
|
232.08M
est: -17.71M (+1,410.2%)
|
35.45M
est: 335.40M (-89.4%)
|
2.13M
est: 36.77M (-94.2%)
|
31.74M
est: 2.15M (+1,376.7%)
|
28.63M
est: 32.25M (-11.2%)
|
54.19M
est: 27.92M (+94.1%)
|
11.50M
est: 28.09M (-59.1%)
|
69.55M
est: 28.90M (+140.6%)
|
33.98M
|
75.21M
est: 69.04M (+8.9%)
|
96.66M
est: 93.79M (+3.1%)
|
108.41M
95.17M – 132.41M
+15.6% YoY
|
126.36M
107.95M – 156.94M
+16.6% YoY
|
144.16M
140.08M – 149.62M
+14.1% YoY
|
| SGA |
72.82M
est: 451.06M (-83.9%)
|
72.63M
est: 45.41M (+60.0%)
|
80.15M
est: 109.61M (-26.9%)
|
74.14M
est: 409.15M (-81.9%)
|
36.54M
est: 62.29M (-41.3%)
|
33.36M
est: 24.86M (+34.2%)
|
37.45M
est: 26.72M (+40.1%)
|
39.06M
est: 52.17M (-25.1%)
|
38.23M
est: 38.58M (-0.9%)
|
39.75M
est: 38.54M (+3.1%)
|
41.15M
est: 40.38M (+1.9%)
|
48.96M
est: 41.29M (+18.6%)
|
69.79M
est: 41.55M (+68.0%)
|
51.08M
est: 42.74M (+19.5%)
|
55.84M
est: 277.48M (-79.9%)
|
1.20B
est: 287.26M (+317.6%)
|
61.22M
est: 331.31M (-81.5%)
|
439.28M
426.54M – 446.99M
+32.6% YoY
|
477.97M
470.73M – 497.02M
+8.8% YoY
|
499.34M
498.06M – 500.62M
+4.5% YoY
|
| EPS |
1.06
est: 1.13 (-6.3%)
|
0.50
est: 0.63 (-20.2%)
|
-0.36
est: 0.48 (-174.3%)
|
0.74
est: 0.44 (+66.5%)
|
0.06
est: 0.20 (-70.3%)
|
-0.21
est: 0.14 (-248.5%)
|
2.64
est: 0.27 (+877.8%)
|
0.40
est: 0.26 (+53.8%)
|
0.02
est: 0.33 (-93.9%)
|
0.36
est: 0.27 (+33.3%)
|
0.32
est: 0.23 (+39.1%)
|
0.60
est: 0.17 (+252.9%)
|
0.13
est: 0.17 (-23.5%)
|
-0.05
est: 0.07 (-172.4%)
|
0.40
|
0.97
est: 0.79 (+22.8%)
|
1.13
est: 1.08 (+4.6%)
|
1.25
1.10 – 1.52
+15.6% YoY
|
1.46
1.24 – 1.81
+16.6% YoY
|
1.66
1.61 – 1.72
+14.1% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-08 | B+ | 3/5 | 2/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-07 | B+ | 3/5 | 2/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-06 | B+ | 3/5 | 2/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-05 | B+ | 3/5 | 2/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-04 | B+ | 3/5 | 2/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-05-01 | B+ | 3/5 | 2/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-30 | B+ | 3/5 | 2/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-29 | B+ | 3/5 | 2/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-28 | B+ | 3/5 | 2/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-27 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-24 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-23 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-22 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-21 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-20 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-17 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
| 2026-04-16 | B+ | 3/5 | 3/5 | 5/5 | 5/5 | 1/5 | 3/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
138.81M
OE per share TTM
1.60
Owner's Yield
4.35%
Maintenance CapEx ratio
53.31%
Maint CapEx / Avg PPE
32.3%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
Held by 51 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Fidelity Canadian High Quality ETF FCCQ.TO | 2.59% | 18.16M | 0.39% |
| 2 | Fidelity Canadian Value ETF FCCV.TO | 2.40% | 20.13M | 0.39% |
| 3 | Fidelity All-Canadian Equity ETF FCCA.NE | 1.43% | 2.07M | 0.39% |
| 4 | NYLI International Small-Mid Cap Equity ETF NISM | 1.11% | 278.1K | 0.70% |
| 5 | iShares S&P/TSX SmallCap Index ETF XCS.TO | 0.91% | 1.56M | 0.60% |
| 6 | Global X - Aging Population ETF AGNG | 0.36% | 312.6K | 0.50% |
| 7 | Fidelity All-in-One Growth ETF FGRO.NE | 0.29% | 10.11M | 0.42% |
| 8 | iShares S&P/TSX Completion Index ETF XMD.TO | 0.28% | 1.55M | 0.60% |
| 9 | Fidelity All-in-One Balanced ETF FBAL.NE | 0.21% | 13.68M | 0.41% |
| 10 | iShares Ageing Population UCITS ETF AGED.L | 0.19% | 1.65M | 0.40% |
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
5.9K
Shares Outstanding
94.82M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Michael R. Guerriere | Chief Executive Officer, President & Director | 2M | — |
| David E. Bacon | Executive Vice President & Chief Financial Officer | 861.5K | male |
| John Toffoletto | Senior Vice President, Chief Legal Officer & Corporate Secretary | 800.2K | male |
| Steve Paraskevopoulos | Senior Vice President of ParaMed & Chief Technology Officer | 695.4K | male |
| Matthew Morgan | Chief Medical Officer | 574.7K | — |
| Katie LeMoyne | Senior Vice President & Chief Human Resources Officer | 520.1K | female |
| Jillian E. Fountain | Vice President of Investor Relations | 291.5K | female |
| Kathryn Bradley | Senior Vice President of Corporate Development | — | female |
| Joe Belinsky | Vice President of Information Technology & Chief Information Officer | — | male |
| Katarina Busija | Chief Nursing Executive & VP | — | female |
| Danielle Labossiere Parr | Vice President of Public Affairs | — | female |
| Mark Trenholm | Senior Vice President of Finance | — | male |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for EXE.TO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
